tiprankstipranks
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
US Market
ASRT
Assertio Therapeutics
RESEARCH TOOLSreports
Want to see ASRT full AI Analyst Report?

Assertio Therapeutics (ASRT) Ratios

1,165 Followers

Assertio Therapeutics Ratios

ASRT's free cash flow for Q4 2025 was $0.76. For the 2025 fiscal year, ASRT's free cash flow was decreased by $ and operating cash flow was $-0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.70 1.70 1.77 1.83 1.39
Quick Ratio
 1.51 1.51 1.43 1.43 1.24
Cash Ratio
 0.08 0.08 0.44 0.79 0.68
Solvency Ratio
 <0.01 <0.01 0.03 -2.05 0.76
Operating Cash Flow Ratio
 -0.22 -0.22 0.23 0.53 0.82
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 167.23
Net Current Asset Value
$ 43.63M$ 43.63M$ 38.90M$ 22.65M$ -55.93M
Leverage Ratios
Debt-to-Assets Ratio
 0.15 0.15 0.14 0.14 0.16
Debt-to-Equity Ratio
 0.42 0.42 0.33 0.29 0.30
Debt-to-Capital Ratio
 0.29 0.29 0.25 0.22 0.23
Long-Term Debt-to-Capital Ratio
 0.29 0.29 0.24 0.22 0.23
Financial Leverage Ratio
 2.84 2.84 2.35 2.08 1.83
Debt Service Coverage Ratio
 4.02 4.30 1.68 -7.31 20.00
Interest Coverage Ratio
 -6.16 -7.00 -8.05 -72.05 4.95
Debt to Market Cap
 0.34 0.67 0.47 0.50 0.33
Interest Debt Per Share
 6.57 6.59 6.82 9.09 23.88
Net Debt to EBITDA
 2.26 2.26 -2.01 -0.64 0.02
Profitability Margins
Gross Profit Margin
70.19%70.19%68.61%82.23%88.00%
EBIT Margin
-14.51%-14.51%-16.55%16.40%36.34%
EBITDA Margin
10.77%10.77%4.12%34.96%57.71%
Operating Profit Margin
-15.95%-18.14%-19.59%-160.15%25.22%
Pretax Profit Margin
-25.22%-25.22%-17.23%-167.06%19.95%
Net Profit Margin
-24.85%-24.85%-17.27%-218.28%70.17%
Continuous Operations Profit Margin
-24.85%-24.85%-17.27%-218.28%70.17%
Net Income Per EBT
98.54%98.55%100.24%130.66%351.75%
EBT Per EBIT
158.09%139.02%87.96%104.32%79.09%
Return on Assets (ROA)
-11.05%-11.05%-7.58%-115.89%26.49%
Return on Equity (ROE)
-29.39%-31.40%-17.82%-240.53%48.57%
Return on Capital Employed (ROCE)
-13.58%-15.44%-14.39%-126.20%12.37%
Return on Invested Capital (ROIC)
-13.58%-15.22%-14.37%-126.20%12.35%
Return on Tangible Assets
-13.53%-13.53%-10.57%-189.59%50.77%
Earnings Yield
-25.46%-50.80%-26.00%-436.75%54.24%
Efficiency Ratios
Receivables Turnover
 0.99 0.99 2.31 3.19 3.44
Payables Turnover
 3.93 3.93 2.66 2.01 3.13
Inventory Turnover
 1.47 1.47 1.02 0.72 1.37
Fixed Asset Turnover
 267.37 267.37 73.03 74.58 177.34
Asset Turnover
 0.44 0.44 0.44 0.53 0.38
Working Capital Turnover Ratio
 1.28 1.34 1.51 2.65 57.60
Cash Conversion Cycle
 525.13 525.12 377.41 441.94 255.97
Days of Sales Outstanding
 369.30 369.30 158.08 114.40 105.96
Days of Inventory Outstanding
 248.81 248.81 356.45 509.08 266.64
Days of Payables Outstanding
 92.99 92.99 137.12 181.54 116.64
Operating Cycle
 618.12 618.11 514.53 623.48 372.61
Cash Flow Ratios
Operating Cash Flow Per Share
 -4.39 -4.40 4.16 10.48 25.08
Free Cash Flow Per Share
 -4.39 -4.40 4.16 10.34 24.99
CapEx Per Share
 0.00 0.00 0.00 0.13 0.09
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 0.99 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 78.99 286.85
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 78.99 286.85
Operating Cash Flow Coverage Ratio
 -0.72 -0.72 0.66 1.25 1.18
Operating Cash Flow to Sales Ratio
 -0.24 -0.24 0.21 0.33 0.50
Free Cash Flow Yield
-24.22%-48.53%31.81%64.44%38.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.93 -1.97 -3.85 -0.23 1.84
Price-to-Sales (P/S) Ratio
 0.98 0.49 0.66 0.50 1.29
Price-to-Book (P/B) Ratio
 1.23 0.62 0.69 0.55 0.90
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.13 -2.06 3.14 1.55 2.58
Price-to-Operating Cash Flow Ratio
 -4.11 -2.06 3.14 1.53 2.57
Price-to-Earnings Growth (PEG) Ratio
 0.07 -0.05 0.04 <0.01 >-0.01
Price-to-Fair Value
 1.23 0.62 0.69 0.55 0.90
Enterprise Value Multiple
 11.36 6.80 14.13 0.79 2.26
Enterprise Value
 145.23M 86.97M 72.69M 42.24M 204.05M
EV to EBITDA
 11.36 6.80 14.13 0.79 2.26
EV to Sales
 1.22 0.73 0.58 0.28 1.31
EV to Free Cash Flow
 -5.15 -3.09 2.75 0.86 2.61
EV to Operating Cash Flow
 -5.15 -3.09 2.75 0.85 2.60
Tangible Book Value Per Share
 7.02 7.03 6.39 5.63 8.85
Shareholders’ Equity Per Share
 14.63 14.67 19.06 29.14 72.03
Tax and Other Ratios
Effective Tax Rate
 -0.01 0.01 >-0.01 -0.31 -2.52
Revenue Per Share
 18.49 18.54 19.67 32.11 49.86
Net Income Per Share
 -4.60 -4.61 -3.40 -70.10 34.98
Tax Burden
 0.99 0.99 1.00 1.31 3.52
Interest Burden
 1.74 1.74 1.04 -10.19 0.55
Research & Development to Revenue
 0.01 0.01 0.03 0.02 0.00
SG&A to Revenue
 0.58 0.58 0.62 0.43 0.29
Stock-Based Compensation to Revenue
 0.02 0.03 0.04 0.06 0.05
Income Quality
 0.93 0.93 -1.22 -0.15 0.72
Currency in USD